DoubleML -- An Object-Oriented Implementation of Double Machine Learning in R
Bach, Philipp, Chernozhukov, Victor, Kurz, Malte S., Spindler, Martin
Structural equation models provide a quintessential framework for conducting causal inference in statistics, econometrics, machine learning (ML), and other data sciences. The package DoubleML for R (R Core Team, 2020) implements partially linear and interactive structural equation and treatment effect models with high-dimensional confounding variables as considered in Chernozhukov et al. (2018). Estimation and tuning of the machine learning models is based on the powerful functionalities provided by the mlr3 package and the mlr3 ecosystem (Lang et al., 2019). A key element of double machine learning (DML) models are score functions identifying the estimates for the target parameter. These functions play an essential role for valid inference with machine learning methods because they have to satisfy a property called Neyman orthogonality. With the score functions as key elements, DoubleML implements double machine learning in a very general way using object orientation based on the R6 package (Chang, 2020). Currently, DoubleML implements the double / debiased machine learning framework as established in Chernozhukov et al. (2018) for - partially linear regression models (PLR), - partially linear instrumental variable regression models (PLIV), - interactive regression models (IRM), and - interactive instrumental variable regression models (IIVM). The object-oriented implementation of DoubleML is very flexible. The model classes DoubleMLPLR, DoubleMLPLIV, DoubleMLIRM and DoubleIIVM implement the estimation of the nuisance functions via machine learning methods and the computation of the Neyman-orthogonal score function.
Mar-17-2021
- Country:
- North America > United States
- Pennsylvania (0.04)
- New York (0.04)
- Europe
- Austria > Vienna (0.14)
- United Kingdom > England
- Cambridgeshire > Cambridge (0.04)
- North America > United States
- Genre:
- Research Report > Experimental Study (0.93)
- Industry:
- Health & Medicine (0.46)
- Technology: